Parenterals

Automating Aseptic Manufacturing

October 03, 2021

Conventional and robotic automation inside closed systems reduces risk.

FDA Approves First HIF-2α Inhibitor Therapy in US

August 18, 2021

FDA approves Merck’s Welireg for the treatment of adult patients with von Hippel-Lindau disease who require therapy for tumor growth.

WHO’s Solidarity Plus Trial to Assess Three Drugs for Hospitalized COVID-19 Patients

August 18, 2021

WHO’s solidarity plus trial will enroll hospitalized patients to test artesunate, imatinib, and infliximab in hospitalized COVID-19 patients.

FDA Approves Expanded Label for Lilly’s Lyumjev

August 18, 2021

Lilly’s insulin, lyumjev, receives FDA approval for an expanded label.

Nitric Oxide Nasal Spray for COVID-19 to Be Distributed to India and Other Asia Markets

August 04, 2021

Glenmark Pharmaceuticals has partnered with SaNOtize to manufacture, market, and distribute NONS to India, Singapore, Malaysia, Hong Kong, and more.

Putting the Patient at the Heart of Dosage Form Design

August 03, 2021

Dosage form priorities are shifting to focus on user-friendliness, leading to greater engagement with outsourcing partners earlier in development timelines.

FDA Approves GSK’s Treatment for Chronic Rhinosinusitis with Nasal Polyps

August 02, 2021

GSK announced that FDA has approved a new indication for Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5.

Continuus Pharmaceuticals Opens Process Development Lab

July 16, 2021

The new lab near Continuus Pharmaceutical’s current facilities in Massachusetts will expand the company’s process development capabilities to high-potency drugs.

Innovations Meet Growing Demand for Prefilled Syringes

July 03, 2021

Container and equipment innovations expand applications.

Amgen Builds Packaging Facility in Ohio

June 30, 2021

Amgen’s greenfield facility near Columbus, Ohio to assemble and package vials and syringes is expected to be operational by 2024.